Xerox (XRX) Q3 2026 Earnings Call Transcript

Xerox reported Q3 revenue of $1.87 billion, down 4.5% in constant currency, while adjusted operating margin improved 330 basis points year over year to 6.6%. It cut full-year adjusted operating income guidance to $450 million–$475 million from $555 million–$605 million and free cash flow guidance to $50 million–$100 million from approximately $250 million, citing input costs, weaker print-market conditions, equipment mix and IT Solutions underperformance. The company suspended common and preferred dividends to preserve about $28 million annually and exchanged approximately $174 million of 2028 notes, reducing principal by $53 million; Lexmark synergies are expected to add $100 million in year-over-year savings in 2027.

Analysis

The key issue is not the impairment itself, but the widening gap between operating progress and cash-generation capacity. Cost savings are visible in operating expenses, while gross profit remains exposed to weak midrange demand, entry-level mix, and input inflation. That makes the 2027 margin case dependent on pricing and further cost actions that are not yet sized; the announced synergy figure alone does not establish that they will cover the headwinds.

The balance-sheet actions improve near-term runway but redistribute risk: exchanging 2028 notes for secured debt and equity reduces principal while potentially leaving remaining unsecured noteholders behind a larger secured claim. Dividend suspension also prioritizes creditors over equity holders. Lower finance receivables release cash, but continued portfolio shrinkage can reduce financing income and potentially constrain a sales lever; the sustainable level of retained receivables and customer-financing capacity needs verification.

The claimed service-cost advantage is a potentially valuable structural differentiator, but remote resolution rates are not yet proof of realized margin expansion. Track technician dispatches per device, post-sale gross margin, renewal rates, and cash conversion. The next 1–3 months’ catalyst is Q4 execution and the 2027 outlook; over 6–18 months, memory costs, price realization, and service productivity determine whether deleveraging resumes. A weaker print market or price resistance could overwhelm savings. Conversely, better gross billings conversion in IT Solutions and measurable post-sale margin improvement would challenge the cautious thesis.

Key Decisions for Investors

• Keep XRX equity underweight / avoid adding ahead of the Q4 2027 outlook: the lowered earnings and cash-flow outlook, suspended dividends, and 4.7x net leverage leave limited room for execution slippage. Reassess if guidance stabilizes and reported free cash flow supports sustained debt reduction.
• For credit, distinguish maturities and lien priority rather than treating the debt stack as one exposure. Review exchange documents and covenants before adding remaining 2028 unsecured notes; the secured exchange may improve maturity management while worsening recoveries for creditors left behind.
• Do not underwrite the 2027 margin recovery to the service narrative alone. Watch post-sale gross margin, service calls and truck rolls per device, and actual pricing realization; failure to improve these measures as costs rise would falsify the cost-to-serve thesis.
• Use Q4 as a cash-conversion test, not just an earnings beat/miss: verify collections, inventory reduction, finance-receivable sales, and tariff-refund timing. Treat any FCF improvement driven mainly by asset sales or timing as lower quality than recurring operating cash generation.